# Complete genome sequence of Limosilactobacillus reuteri strain iVE-9, isolated from the fecal sample of a healthy human

**Authors:** Mallory J. Van Haute, Katherine Chacón-Vargas, Shara R. P. Yumul, Chloe M. Christensen, Robert Hutkins, Thomas A. Auchtung

PMC · DOI: 10.1128/mra.01134-25 · 2025-11-24

## TL;DR

This paper reports the full genome of a L. reuteri strain from a human fecal sample, highlighting its potential health benefits.

## Contribution

The complete genome sequence of L. reuteri iVE-9 is newly presented with its encoded beneficial metabolic traits.

## Key findings

- The genome encodes production of exopolysaccharides and B vitamins.
- It includes genes for bacteriocin and gamma-aminobutyric acid synthesis.
- The strain produces indole-3-lactic acid, suggesting probiotic potential.

## Abstract

Limosilactobacillus reuteri inhabits the gastrointestinal tract of a variety of hosts. Here, we present the complete genome sequence of a human isolate, L. reuteri iVE-9, that encodes for several potentially beneficial metabolic traits, including production of exopolysaccharides, B vitamins, a bacteriocin, indole-3-lactic acid, and gamma-aminobutyric acid.

## Linked entities

- **Chemicals:** indole-3-lactic acid (PubChem CID 92904), gamma-aminobutyric acid (PubChem CID 119)
- **Species:** Limosilactobacillus reuteri (taxon 1598)

## Full-text entities

- **Chemicals:** indole-3-lactic acid (MESH:C024139), gamma-aminobutyric acid (MESH:D005680), exopolysaccharides (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12797992/full.md

---
Source: https://tomesphere.com/paper/PMC12797992